Comparison of ovarian follicular activity during treatment with a monthly injectable contraceptive and a low-dose oral contraceptive

Contraception

Volumn 61, Issue 3, 2000, Pages 195-198

  Jain, John K ^a   Ota, Felicia ^a   Mishell Jr , Daniel R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Follicle; Lunelle; Oral contraceptive pill

Indexed keywords

ESTRADIOL CYPIONATE PLUS MEDROXYPROGESTERONE ACETATE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ECHOGRAPHY; FEMALE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; OVARY FOLLICLE CELL; OVARY FOLLICLE DEVELOPMENT; OVULATION; OVULATION INHIBITION; RANDOMIZED CONTROLLED TRIAL;

AMERICAS; BIOLOGY; CALIFORNIA; CLINICAL RESEARCH; COMPARATIVE STUDIES; CONTRACEPTION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE AGENTS, PROGESTIN; CONTRACEPTIVE METHODS; DEVELOPED COUNTRIES; ENDOCRINE SYSTEM; ESTRADIOL; ESTROGENS; FAMILY PLANNING; GENITALIA; GENITALIA, FEMALE; HORMONES; INJECTABLES; MEDROXYPROGESTERONE ACETATE; NORTH AMERICA; NORTHERN AMERICA; ORAL CONTRACEPTIVES; ORAL CONTRACEPTIVES, LOW-DOSE; OVARIAN EFFECTS; OVARY; PHYSIOLOGY; RESEARCH METHODOLOGY; RESEARCH REPORT; STUDIES; UNITED STATES; UROGENITAL SYSTEM;

ADULT; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; DRUG COMBINATIONS; ESTRADIOL; ETHINYL ESTRADIOL; FEMALE; HUMANS; INJECTIONS; LEVONORGESTREL; MEDROXYPROGESTERONE 17-ACETATE; OVARIAN FOLLICLE; PROSPECTIVE STUDIES;

EID: 0034109176     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(00)00098-6     Document Type: Article

References (20)

1. A multicentered phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection. I contraceptive efficacy and side effects . Contraception. 37:1998;1-20.
2. Facts about once-a-month injectable contraceptives memorandum from a WHO meeting . Bull WHO. 71:1993;677-689.
3. Sang G.W., Shao Q.X., Ge R.S., et al. A multicentered phase III comparative clinical trial of Mesigyna, Cyclofem and injectable no 1 given by intramuscular injection to Chinese women. II comparison of bleeding patterns . Contraception. 51:1995;185-192.
4. Cuong D.T., My Huong N.T. Comparative phase III clinical trial of two injectable contraceptive preparations, depot-medroxyprogesterone acetate and Cyclofem, in Vietnamese women. Contraception. 54:1996;169-179.
5. Hall PE, Task Force on Research on Introduction and Transfer of Technologies for Fertility Regulation. Special Programme of Research, Development and Research Training in Human Reproduction. World Health Organization, Geneva, Switzerland. The introduction of Cyclofem into national family planning programmes. Experience from studies in Indonesia, Jamaica, Mexico, Thailand and Tunisia. Contraception 1994;49:489-507.
6. Kaunitz A.M., Garceau R.J., Cromie M.A. Comparative safety, efficacy and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive. Contraception. 60:1999;179-187.
7. Hall P., Bahamondes L., Diaz J., Petta C. Introductory study of the once-a-month injectable contraceptive Cyclofem in Brazil, China, Columbia and Peru. Contraception. 56:1997;353-359.
8. Aedo A.R., Langren B.M., Johannisson E., Diczfalusy E. Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations. Contraception. 31:1985;453-469.
9. Shoupe D., Horenstein J., Mishell D.R., Lacarra M., Medearis A. Characteristics of ovarian follicular development in Norplant users. Fertil Steril. 55:1991;766-770.
10. Tayob Y., Adams J., Jacobs H.S., Guillebaud J. Ultrasound demonstration of increased frequency of functional ovarian cysts using progestogen-only oral contraception. Br J Obstet Gynaecol. 92:1985;1003-1009.
11. Langren B.M., Diczfalucy E. Hormonal effects of the 300 μg norethisterone (NET) mini pill. Contraception. 21:1980;87-113.
12. Grimes D.A., Godwin A.J., Rubin A., Smith J.A., Lacarra M. Ovulation and follicular development associated with three low-dose oral contraceptives a randomized controlled trial . Obstet Gynecol. 83:1994;29-34.
13. Coney P., Del Conte A. The effects on ovarian activity of a monophasic oral contraceptive with 100 μg levonorgestrel and 20 μg ethinyl estradiol. Am J Obstet Gynecol. 181:1999;S53-S58.
14. Long acting methods of contraception. In: Speroff L, Glass RH, Kase NG, eds. Clinical Gynecologic Endocrinology and Infertility, 6th Edition. Baltimore: Lippincott, Williams and Wilkins, 1999;958.
15. Zelinski-Wooten M.B., Hutchison J.S., Hess D.L., Wolf D.P., Stouffer R.L. Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotropin-releasing hormone antagonist-treated monkeys. Hum Reprod. 10:1995;1658-1666.
16. Mall-Haefeli M., Werner-Zodrow I., Hulser P.R., et al. Oral contraception and ovarian function. Runnebaum B., Rabe T., Kiesel L. Female Contraception. 1988;97-105 Springer-Verlag, Berlin.
17. Spona J., Feichtinger W., Kindermann C., Wunsch C., Brill K. Inhibition of ovulation by an oral contraceptive containing 100 μg levonorgestrel in combination with 20 μg ethinyl estradiol. Contraception. 54:1996;299-304.
18. Hoogland H.J., Skouby S.O. Ultrasound evaluation of ovarian activity under oral contraceptives. Contraception. 47:1993;583-590.
19. Spanos W.J. Preoperative hormonal therapy of cystic adnexal masses. Am J Obstet Gynecol. 116:1973;551-556.
20. Steinkampf M.P., Hammond K.R., Blackwell R.E. Hormonal treatment of functional ovarian cysts A randomized prospective study . Fertil Steril. 54:1990;775-777.